<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03732898</url>
  </required_header>
  <id_info>
    <org_study_id>A4058</org_study_id>
    <nct_id>NCT03732898</nct_id>
  </id_info>
  <brief_title>Coordinated Reset Deep Brain Stimulation</brief_title>
  <acronym>RESET-DBS</acronym>
  <official_title>Coordinated Reset Deep Brain Stimulation (RESET-DBS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will explore the viability of an alternative programming strategy in Deep Brain
      Stimulation (DBS) for patients with Parkinson's Disease (PD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will explore the feasibility of utilizing an alternative programming technique in
      Deep Brain Stimulation (DBS) for patients with Parkinson's Disease (PD).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 13, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in Quality of Life using new programming paradigm: PDQ-39</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>Change in Parkinson's Disease Questionnaire (PDQ-39) summary index and sub-scores</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Parkinson's Disease (PD)</condition>
  <arm_group>
    <arm_group_label>New Programming Paradigm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will include patients receiving stimulation with a new programming paradigm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>New Programming Paradigm</intervention_name>
    <description>A new programming paradigm will be evaluated.</description>
    <arm_group_label>New Programming Paradigm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          1. Subject with PD implanted bilaterally in the STN and receiving DBS therapy for at
             least 3 months.

          2. Tolerates &gt; 12 hours OFF medication and, per clinical judgment, be able to perform all
             study related procedures.

          3. Able to understand the study requirements and the treatment procedures and must
             provide written informed consent before any study-specific tests or procedures are
             performed.

        Key Exclusion Criteria:

          1. Exhibits significant psychiatric problems, including unrelated clinically significant
             depression as determined by the investigator.

          2. A female who is pregnant, is breastfeeding, or is of childbearing potential and
             planning to get pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roshini Jain</last_name>
    <role>Study Director</role>
    <affiliation>Boston Scientific Neuromodulation Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diane Bowers</last_name>
    <phone>661-949-4175</phone>
    <email>diane.bowers@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roshini Jain</last_name>
    <phone>469-766-9888</phone>
    <email>roshini.jain@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Scientific Clinical Research</name>
      <address>
        <city>Diegem</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific</last_name>
      <phone>855-213-9890</phone>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <removed_countries>
    <country>Netherlands</country>
    <country>United States</country>
  </removed_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 30, 2018</study_first_submitted>
  <study_first_submitted_qc>November 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2018</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

